The USAID Bureau for Global Health (GH), awarded ME&A a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract to provide evaluation, assessment, and learning support for health-related projects and activities at USAID/Washington and USAID Missions in May of 2020. Projects within GH’s portfolio support the U.S. Government’s goals to improve global health through preventing child and maternal deaths; controlling the HIV/AIDS epidemic; and combating infectious diseases, such as COVID-19.
Under the Global Health Evaluation and Learning Support Activity, ME&A and our subcontractor, Dexis, provide assessments, performance and impact evaluations, and learning and adaptive management services that are transparent, based on the best methods, and oriented towards reinforcing local ownership. This includes four types of evaluations of President’s Emergency Plan For AIDS Relief (PEPFAR) programs: process, outcome, economic, and impact. PEPFAR is a U.S. governmental initiative to address the global HIV/AIDS epidemic.
The contract also involves coordinating and collaborating, as appropriate, with USAID partners, to build synergies and improve the effectiveness and efficiency of project activities. These include the U.S. Centers for Disease Control and Prevention (CDC); the Global Fund to Fight AIDS, TB, and Malaria (GFATM); and GH cooperating agency implementing partners, such as U.S. and international nongovernmental organizations and private corporations and foundations.
ME&A manages the Global Health Evaluation and Learning Support Activity IDIQ with a $39 million ceiling from our headquarters in Bethesda, Md., through 2025.
Contact: Mirela McDonald